Atlas Trials

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205

Clinical trial NCT07634510 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07634510
Sponsor
Shanghai Minwei Biotechnology Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemias
Start date
2026-06-22
Primary completion
2026-10-26
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.